# Xenon Pharmaceuticals Inc.: Form 8-K, filed Jun 5, 2024

- Company: [Xenon Pharmaceuticals Inc.](/companies/xene.md) (CIK 1582313)
- Form: 8-K
- Filed: 2024-06-05
- Accepted by EDGAR: Jun 5, 2024, 20:12 ET
- Period: 2024-06-04
- Accession: 0000950170-24-069318
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1582313/000095017024069318/xene-20240604.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1582313/000095017024069318/

## Items reported

- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1582313/000095017024069318/xene-20240604.htm

Filed Jun 5, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-069318. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.